Prenatal alcohol exposure is widely known to impair brain development in exposed offspring. Rodent studies have shown that developmental deficits in newborns related to altered levels of a brain chemical called serotonin (5-HT), leading to subsequent alterations in patterns of neonatal acute pain responses and/or hypothalamic-pituitary-adrenal (HPA) stress reactivity. New findings show a "blunted response" to an acutely painful event - a heel lance - in alcohol-exposed human newborns, indicating that prenatal alcohol exposure may alter the brain's developing pain regulatory system. Results will be published in the April 2010 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.
Holiday shopping and holiday feasting may make you a prime candidate for a case of plantar fasciitis. Prolonged walking or standing and an increase in body weight are two leading causes of plantar fasciitis, a painful overuse injury affecting the sole of the foot, warns the American Orthopaedic Foot & Ankle Society (AOFAS). According to the AOFAS, plantar fasciitis typically starts gradually with mild heel pain. The pain classically occurs with the first step in the morning. Treatment options include stretching exercises, and modifying activities until the initial inflammation goes away. Ice application to the sore area for 20 minutes three or four times a day may also relieve symptoms.
As the leading professional society devoted exclusively to pain, pain management and pain research, the American Pain Society sponsors the Kathleen M. Foley Journalist Award to recognize excellence in reporting pain-related topics. The award is designed to honor the work of journalists whose coverage of events, scientific discoveries, patient care, issues and policies contribute to furthering public awareness and understanding of pain and pain-related issues. APS is accepting applications for the 2010 Foley Award, which will be presented at the APS Annual Scientific Meeting in Baltimore, May 6-8. Nominations will be accepted until Feb.
China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase III Registration Clinical Study Of Tilidine For Moderate To Severe Pain
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it completed Phase III clinical study for Tilidine tablets, a novel drug in China to treat acute and chronic moderate to severe pain, including post-operative and cancer pain in adult patients. The drug is designated as a Class III New Medicine with approximately at least four-year market exclusivity protection upon marketing clearance by the China SFDA. "Reaching this pivotal milestone is an important event for the development of our Tilidine franchise, and will enable a complete analysis of the trial results and a timely submission of new drug application (NDA) to the China SFDA.
Study Examines Smoking Practices And Attitudes Among Anesthesiologists In China, The Country With The Highest Population Of Smokers
The statistics are frightening: one-third of the world's smokers (300 million) live in China, and chronic diseases caused by smoking are a growing burden to public health there. Current projections estimate that the number of tobacco-related deaths in China will increase to 2 million annually by 2025. A new study in the February issue of the journal Anesthesiology looks at whether Chinese anesthesiologists are willing to help their patients quit smoking, and ultimately help reduce these projected tobacco-related deaths. Because patients in the U.S. are advised to abstain from smoking for as long as possible both before and after surgery, the study's lead author believes it represents a golden opportunity for people to take action to quit, and he is committed to supporting the campaign across the globe.
A simple yet enormously effective patient surveillance system implemented by anesthesiologists at Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, New Hampshire has proven to dramatically decrease the number of rescue calls and intensive care unit transfers in postsurgical patients, allowing doctors to intervene in more cases before a crisis situation develops. Andreas H. Taenzer, M.D., F.A.A.P. and his colleagues published the results of their study in the February 2010 issue of Anesthesiology. The group's study is the first published report of such a surveillance monitoring system, which seeks to detect patient adverse events occurring in the general postoperative care setting when medical staff is immediately available to intervene, but is unaware of the deteriorating condition.